NO20083853L - Nye forbindelser - Google Patents

Nye forbindelser

Info

Publication number
NO20083853L
NO20083853L NO20083853A NO20083853A NO20083853L NO 20083853 L NO20083853 L NO 20083853L NO 20083853 A NO20083853 A NO 20083853A NO 20083853 A NO20083853 A NO 20083853A NO 20083853 L NO20083853 L NO 20083853L
Authority
NO
Norway
Prior art keywords
compounds
new connections
conditions
medicament
administered
Prior art date
Application number
NO20083853A
Other languages
English (en)
Inventor
Robert Felix Galyean
Kazimierz Wisniewski
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of NO20083853L publication Critical patent/NO20083853L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen angår nye forbindelser, farmasøytiske sammensetninger omfattende samme, anvendelse av nevnte forbindelser for fremstillingen av et medikament for behandlingen av blant annet sjokktilstander så vel som en metode for behandling av nevnte tilstander, hvori nevnte forbindelser blir administrert. Forbindelsene er representert ved den generelle formelen (I), som ytterligere definert i beskrivelsen.
NO20083853A 2006-02-10 2008-09-08 Nye forbindelser NO20083853L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77187006P 2006-02-10 2006-02-10
PCT/US2007/003213 WO2007095021A2 (en) 2006-02-10 2007-02-05 Novel compounds

Publications (1)

Publication Number Publication Date
NO20083853L true NO20083853L (no) 2008-09-30

Family

ID=38371994

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083853A NO20083853L (no) 2006-02-10 2008-09-08 Nye forbindelser

Country Status (13)

Country Link
US (1) US8883965B2 (no)
EP (1) EP1981900B1 (no)
JP (1) JP5185830B2 (no)
KR (1) KR101194586B1 (no)
CN (1) CN101379076B (no)
AU (1) AU2007215406B2 (no)
CA (1) CA2641959C (no)
ES (1) ES2535434T3 (no)
IL (1) IL192824A (no)
NO (1) NO20083853L (no)
NZ (1) NZ569836A (no)
RU (1) RU2415149C2 (no)
WO (1) WO2007095021A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
NZ569836A (en) 2006-02-10 2010-09-30 Ferring Bv Novel compounds
US9050286B2 (en) 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists
ES3058497T3 (en) 2008-09-17 2026-03-11 Amryt Endo Inc Pharmaceutical compositions comprising polypeptides and related methods of delivery
TWI463990B (zh) * 2009-09-21 2014-12-11 Ferring Bv 催產素受體促進劑
IL313083A (en) 2016-10-21 2024-07-01 Amryt Endo Inc Terlipressin compositions and their methods of use
MX2020013389A (es) * 2018-06-15 2021-03-31 Ferring Bv Composiciones de terlipresina y usos de las mismas.

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1076984A (en) 1963-04-05 1967-07-26 Sandoz Ltd Improvements in or relating to local anaesthetics containing orn-vasopressin
NL129421C (no) * 1963-08-30 1900-01-01
CS235151B1 (cs) 1982-08-26 1985-05-15 Michal Lebl Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en) * 1983-04-05 1989-05-09 Vega Laboratories, Inc. N-substituted derivatives of 1-desaminovasopressin
US4483794A (en) * 1983-05-10 1984-11-20 Ceskoslovenska Akademie Ved Analogs of neurohypophysial hormones
CS242062B1 (cs) 1984-08-23 1986-04-17 Milan Zaoral Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv) 1986-08-18 1988-11-28 Ferring Ab Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv) 1987-10-07 1993-07-12 Ferring Ab Vasoaktiva peptider
SE502644C2 (sv) * 1990-02-27 1995-11-27 Ferring Ab Vasoaktiva vasotocinderivat
RU2063979C1 (ru) 1992-02-24 1996-07-20 Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов Пептиды последовательности окситоцина
US5516795A (en) * 1994-09-12 1996-05-14 Abbott Laboratories Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
RU2073010C1 (ru) * 1994-10-26 1997-02-10 Российско-германское совместное предприятие "Константа" Способ синтеза лизин-вазопрессина в растворе
GB9617021D0 (en) * 1996-08-13 1996-09-25 Salpep Biotechnology Inc Novel peptides for treatment of inflammation and shock
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II
SE9701161D0 (sv) 1997-03-27 1997-03-27 Karolinska Innovations Ab New use I
AU757658B2 (en) 1998-03-09 2003-02-27 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
US20030109670A1 (en) * 2001-02-09 2003-06-12 University Of Utah Research Foundation Cone snail peptides
JPWO2003082334A1 (ja) 2002-03-29 2005-07-28 わかもと製薬株式会社 涙液増大薬
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
EP1556068B1 (en) 2002-10-03 2010-08-18 Neuropharmacology Services, LLC Oxytocin for use in the treatment of Autism and Asperger's disorder
CA2557520C (en) * 2003-02-26 2011-09-13 Donald W. Landry A method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) * 2004-08-11 2016-03-15 فيرينغ.بي.في Tight muscles of the peptide vascular tensioner receptor
NZ569836A (en) * 2006-02-10 2010-09-30 Ferring Bv Novel compounds
DK1984012T3 (en) * 2006-02-13 2016-03-29 Ferring Bv USE OF peptidic vasopressin receptor agonists
RU2342949C1 (ru) 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
US9050286B2 (en) * 2007-08-14 2015-06-09 Ferring B.V. Use of peptidic vasopression receptor agonists

Also Published As

Publication number Publication date
RU2008131907A (ru) 2010-03-20
JP2009526061A (ja) 2009-07-16
EP1981900B1 (en) 2015-01-28
EP1981900A4 (en) 2011-01-26
IL192824A0 (en) 2011-08-01
CN101379076A (zh) 2009-03-04
EP1981900A2 (en) 2008-10-22
RU2415149C2 (ru) 2011-03-27
AU2007215406A1 (en) 2007-08-23
US20090275522A1 (en) 2009-11-05
CA2641959C (en) 2016-12-20
NZ569836A (en) 2010-09-30
WO2007095021A3 (en) 2008-04-24
ES2535434T3 (es) 2015-05-11
CN101379076B (zh) 2012-11-07
WO2007095021A2 (en) 2007-08-23
AU2007215406B2 (en) 2011-12-08
HK1116807A1 (en) 2009-01-02
US8883965B2 (en) 2014-11-11
CA2641959A1 (en) 2007-08-23
IL192824A (en) 2015-04-30
KR20080091802A (ko) 2008-10-14
KR101194586B1 (ko) 2012-10-25
JP5185830B2 (ja) 2013-04-17

Similar Documents

Publication Publication Date Title
NO20071314L (no) Peptidiske vasopressinreseptoragonister
NO20091599L (no) Kjemiske forbindelser
WO2009155121A3 (en) Inhibitors of pi3 kinase
WO2009122285A8 (en) Oxytocin analogues
EA201100299A1 (ru) Органические соединения
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201491060A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
EA201270560A1 (ru) Спиропиперидиновые соединения и их фармацевтическое применение для лечения диабета
EA201201677A1 (ru) Производные гетероарилимидазолона в качестве ингибиторов jak
EA200870423A1 (ru) Производные триазолпиразинов, применимые в качестве противораковых агентов
MX2011011335A (es) Inhibidores de fosfoinositida 3 cinasa y/u objetivo mamifero de rapamicina.
EA201100503A1 (ru) Глюкозидные производные и их применения
DK2150530T3 (da) Substituerede sulfonamid-derivater
EA201300250A1 (ru) Оксадиазольные ингибиторы продуцирования лейкотриена
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA201290416A1 (ru) Новые спиропиперидиновые соединения
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
EA201391525A1 (ru) Гликозидные производные и их применение для лечения диабета
TW200616979A (en) Non-nucleoside reverse transcriptase inhibitors
MA32943B1 (fr) Piperidine spiro pyrrolidione et piperidinone substituees, leur preparation et leur utilisation therapeutique
EA201071269A1 (ru) 3,4-замещенные пиперидиновые производные в качестве ингибиторов ренина
CY1109569T1 (el) Υποκατεστημενα παραγωγα κυκλοεξανο-1,4-διαμινης
WO2008098978A3 (en) Benzofuran compounds useful in the treatment of conditions mediated by the action of pge2 at the ep1 receptor
WO2007095021A3 (en) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application